|
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical research trials and Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria). Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
For Condition: Neutropenia,Fever,Neoplasms,Gram-Positive Bacterial Infections
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria)
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: - Patients must have neutropenia (ANC less than 500) with fever (oral temp 38.3 C). - Patients must have a cancer with recent chemotherapy and risks factors for gram positive infections. Exclusion Criteria: - Patients with fever due to known causes. - Patients with HIV. - Patients with recent bone marrow transplant. - Patients with an infected indwelling catheter that cannot be removed. - Patients who have received more than one day of another antibiotic before entering the trial. - Patients with endocarditis, osteomyelitis, meningitis, CNS infections.
Total Enrollment:
Location and Contact Information:
Research Center
Tacoma, Washington, 98405
United States
Research Center
Richmond, Virginia, 23249
United States
Research Center
Lexington, Kentucky, 40536
United States
Research Center
Los Angeles, California, 90033
United States
Research Center
Bronx, New York, 10467-2490
United States
Research Center
Kalamazoo, Michigan, 49001
United States
Research Center
Maywood, Illinois, 60153
United States
Research Center
Houston, Texas, 77030-4211
United States
Research Center
Youngstown, Ohio, 44501
United States
Research Center
Springfield, Illinois, 62701
United States
Research Center
Richmond, Virginia, 23294
United States
Research Center
Houston, Texas, 77030
United States
Research Center
Falls Church, Virginia, 22042
United States
Research Center
Worcester, Massachusetts, 01655
United States
Research Center
Orange, California, 92868
United States
Research Center
Jackson, Tennessee, 38301
United States
Research Center
San Diego, California, 92134
United States
Research Center
Perth Amboy, New Jersey, 08861
United States
Research Center
Hato Rey, , 00985
Puerto Rico
Research Center
Milwaukee, Wisconsin, 53226
United States
Research Center
Miami, Florida, 33136
United States
Additional Information:
Study ID Numbers: M/1260/0079;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035425
Other Gram-Positive Bacterial Infections Studies:
1. Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
2. Dose Determination of 5-Fluorouracil in Combination with Leucovorin and the Experimental Drug UCN-01 to Treat Cancer
3. Developmental Study on Fatigue in Cancer
4. Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System
5. Study to Determine the Maximum Tolerated Dose of LErafAON in Patients with Advanced Solid Tumors
Related Studies:
Other Gram-Positive Bacterial Infections Clinical Trials
Other Clinical Trials
Other Hato Rey Clinical Trials
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
|
|
|
|
|
|
|
|